➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Dow
Boehringer Ingelheim
AstraZeneca
Baxter

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

Claims for Patent: 5,290,924

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 5,290,924
Title: Recombinant promoter for gene expression in monocotyledonous plants
Abstract:A recombinant promoter molecule for enhancing expression of a plant-expressible structural gene in a monocot plant cell is provided comprising a plurality of enhancer elements selected from the group consisting of ARE and OCS elements, a truncated plant-expressible promoter, and an intron.
Inventor(s): Last; David I. (Holt, ACT, AU), Brettell; Richard I. S. (Kambah, ACT, AU), Chamberlain; Douglas A. (Farrer, ACT, AU), Larkin; Philip J. (Weston, ACT, AU), Marsh; Ellen L. (Braddon, ACT, AU), Peacock; James W. (Deakin, ACT, AU), Dennis; Elizabeth S. (Yarralumla, ACT, AU), Olive; Mark R. (Cook, ACT, AU), Ellis; Jeffrey G. (Macquarie, ACT all of, AU)
Assignee:
Application Number:08/051,006
Patent Claims:1. A recombinant promoter molecule, useful for enhancing expression of a plant-expressible structural gene in a monocot plant cell, said promoter molecule comprising:

(a) a plurality of enhancer elements selected from the group consisting of only ARE elements, only OCS elements, and combinations of ARE and OCS elements;

(b) a truncated, plant expressible promoter, providing a TATA box region and a transcription start site, said promoter selected from the group consisting of .DELTA.35S and .DELTA.ADH positioned 3' to said plurality of enhancer elements wherein said truncated promoter excludes the presence of enhancer sequences and wherein said truncated promoter is recombined with said plurality of enhancer elements positioned 5' to said truncated promoter; and

(c) a maize Adh1 intron positioned 3' to said transcription start site whereby a plant-expressible structural gene, placed 3' to said recombinant promoter molecule, is expressed in said monocot plant cell under regulatory control of said recombinant promoter molecule.

2. The recombinant promoter molecule of claim 1 having the structure 4OCS.DELTA.35SI where 4 OCS refers to 4 tandemly repeated copies of OCS each OCS having the nucleotide sequence as shown in SEQ ID:1, .DELTA.35S is a truncated CAMV 35S promoter having the nucleotide sequence as shown in SEQ ID:2, and I is the Adh1 intron, having the nucleotide sequence as shown in SEQ ID:5.

3. The recombinant promoter molecule of claim 1 having the structure 6ARE.DELTA.ADHI, wherein 6ARE refers to 6 tandemly repeated copies of ARE, each ARE having the nucleotide sequence as shown in SEQ ID:3, .DELTA.ADH is a truncated Adh1 promoter having the nucleotide sequence shown in SEQ ID:4, and I is the Adh1 intron having the nucleotide sequence shown in SEQ ID:5.

4. The recombinant promoter molecule of claim 1 having the structure 6ARE4OCS.DELTA.ADHI, wherein 6 ARE refers to 6 tandemly repeated copies of ARE, each ARE having the nucleotide sequence as shown in SEQ ID:3, 4OCS refers to 4 tandemly repeated copies of OCS, each OCS having the nucleotide sequence as shown in SEQ ID:1, .DELTA.ADH is a truncated Adh promoter, and I is the Adh1 intron having the nucleotide sequence as shown in SEQ ID:5.

5. A vector comprising said recombinant promoter molecule of claim 1.

6. A bacterial cell containing the vector of claim 5.

7. A transformable, regenerable monocot plant transformed to comprise the recombinant promoter molecule of claim 1 and a plant-expressible structural gene placed 3' to said recombinant promoter molecule such that said structural gene is expressed under control of said recombinant promoter molecule.

8. A plant of claim 7 selected from the group consisting of maize, wheat, barley, and rice.

9. A transformable, regenerable monocot plant cell transformed to comprise the recombinant promoter molecule of claim 1 and a plant-expressible structural gene placed 3' to said recombinant promoter molecule such that said structural gene is expressed under control of said recombinant promoter molecule.

10. A maize cell of claim 9.

11. A wheat cell of claim 9.

12. A barley cell of claim 9.

13. A rice cell of claim 9.

14. The recombinant promoter molecule of claim 1 wherein said ARE elements have the nucleotide sequence disclosed in SEQ ID NO:3.

15. The recombinant promoter molecule of claim 1 wherein said OCS elements have the nucleotide sequence disclosed in SEQ ID NO:1.

16. The recombinant promoter molecule of claim 1 wherein said .DELTA.35S promoter has the nucleotide sequence disclosed in SEQ ID NO:2.

17. The recombinant promoter molecule of claim 1 wherein said .DELTA.ADH promoter has the nucleotide sequence disclosed in SEQ ID NO:4.

18. The recombinant promoter molecule of claim 1 wherein said Adh1 intron has the nucleotide sequence disclosed in SEQ ID NO:5.

Details for Patent 5,290,924

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ⤷  Try it Free 2011-03-01 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ⤷  Try it Free 2011-03-01 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ⤷  Try it Free 2011-03-01 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Johnson and Johnson
Express Scripts
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.